QC
LXRX icon

Quadrature Capital’s Lexicon Pharmaceuticals LXRX Stock Holding History

Quadrature Capital’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52.8K Sell
21,998
-88,381
-80% -$172K ﹤0.01% 1511
2026
Q1 		$172K Buy
110,379
+91,965
+499% +$134K ﹤0.01% 1150
2025
Q4 		$21.2K Sell
18,414
-209,795
-92% -$288K ﹤0.01% 1206
2025
Q3 		$309K Buy
+228,209
New +$259K ﹤0.01% 660

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Quadrature Capital's LXRX Position: Q2 2026 in Review

Quadrature Capital reduced its Lexicon Pharmaceuticals (LXRX) stake by 80% in Q2 2026, selling an estimated $172K and leaving 21,998 shares worth $52.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1511.

Quadrature Capital first reported a position in LXRX in Q3 2025 and has held it in 4 quarters since. The position peaked at $309K in Q3 2025. 149 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

  • Quadrature Capital held 21,998 shares of Lexicon Pharmaceuticals worth $52.8K as of Q2 2026.
  • Quadrature Capital sold 88,381 Lexicon Pharmaceuticals shares in Q2 2026, an estimated $172K.
  • Lexicon Pharmaceuticals made up ﹤0.01% of Quadrature Capital's portfolio in Q2 2026, its #1511 holding.
  • Quadrature Capital first reported a position in Lexicon Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Quadrature Capital's Lexicon Pharmaceuticals position peaked at $309K in Q3 2025.
  • 149 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.